Akorn, Inc. Report issue

Contributed to NME For profit Phase 2 Phase 3 Phase 4
Founded: Abita Springs LA United States (1971)
Status: No NME R&D (1971)

Organization Overview

First Clinical Trial
2004
NCT00344721
First Marketed Drug
1971
dimercaprol
First NDA Approval
1984
sufentanil
Last Known Activity
2018

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Advanced Vision Research | AKORN | Akorn, Inc. | AKORN INC | Akorn Ophthalmic | Oak Pharmaceuticals | OAK PHARMS | OAK PHARMS AKORN | OAK PHARMS INC